135 CIBA Pill - white oval
Generic Name: maprotiline
Pill with imprint 135 CIBA is White, Oval and has been identified as Ludiomil 75 MG. It is supplied by Novartis Pharmaceuticals.
Ludiomil is used in the treatment of Depression; Major Depressive Disorder and belongs to the drug class tetracyclic antidepressants. There is no proven risk in humans during pregnancy. Ludiomil 75 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for 135 CIBA
Ludiomil
- Generic Name
- maprotiline
- Imprint
- 135 CIBA
- Strength
- 75 MG
- Color
- White
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclic antidepressants
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00083-0135 (Discontinued)
See also:
Auvelity
Auvelity (dextromethorphan and bupropion) is used to treat major depressive disorder. Includes ...
Lexapro
Lexapro is used to treat anxiety and major depressive disorder. Learn about side effects ...
Vraylar
Vraylar is a once a day antipsychotic medication used to treat mental health or mood disorders ...
Zoloft
Zoloft is an antidepressant used to treat major depression, obsessive-compulsive disorder, panic ...
Seroquel
Seroquel is used to treat the symptoms of schizophrenia, bipolar disorder and major depressive ...
Prozac
Prozac (fluoxetine) is an SSRI antidepressant used to treat depression, OCD, panic disorder ...
Cymbalta
Cymbalta (duloxetine) is used to treat major depressive disorder, general anxiety disorder and ...
Wellbutrin
Wellbutrin (bupropion) is used to treat major depressive disorder and seasonal affective disorder ...
Celexa
Celexa (citalopram) is an antidepressant in a group of drugs called selective serotonin reuptake ...
More about Ludiomil (maprotiline)
- Check interactions
- Compare alternatives
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclic antidepressants
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.